Adam Sutherland
Overview
Explore the profile of Adam Sutherland including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sutherland A, Phipps D, Tomlin S, Grant S, Hughes J, Chambers J, et al.
Health Expect
. 2025 Feb;
28(1):e70161.
PMID: 39924680
Introduction: Medication safety in healthcare settings is a persistent problem, and children may be at greater risk of harm than adults. Most existing research examining medication safety for hospitalised children...
2.
Sutherland A, Phipps D, Gill A, Morris S, Ashcroft D
J Patient Saf
. 2023 Nov;
20(1):7-15.
PMID: 37921742
Objectives: Medication is a common cause of preventable medical harm in pediatric inpatients. This study aimed to examine the sociotechnical system surrounding pediatric medicines management, to identify potential gaps in...
3.
Jandot E, Savelli M, Pinte G, Sutherland A, Quessada T, Valla F
Nutr Clin Pract
. 2022 Nov;
38(3):698-706.
PMID: 36420832
Background: Parenteral nutrition (PN) is sometimes required in critically ill children because of contraindication or intolerance to full enteral nutrition. European guidelines recommend favoring multichamber bag PN (MCB PN), when...
4.
Sutherland A, Jones M, Howlett M, Arenas-Lopez S, Patel A, Franklin B
Drug Saf
. 2022 Jul;
45(8):881-889.
PMID: 35838875
Avoidable harm associated with medication is a persistent problem in health systems and the use of preprogrammed infusion devices ('smart pumps') and data monitoring is seen as a core approach...
5.
Sutherland A, Gerrard W, Patel A, Randall M, Weston E
BMJ Open Qual
. 2022 Jul;
11(3).
PMID: 35820711
Introduction: The use of intravenous administration systems with dose error reduction software (DERS) is advocated to mitigate avoidable medication harm. No large-scale analysis of UK data has been attempted. This...
6.
Alghamdi A, Keers R, Sutherland A, Hann M, Gray J, Mason G, et al.
Br J Clin Pharmacol
. 2021 Dec;
88(5):2213-2222.
PMID: 34878686
Aims: The aim of this study was to assess the incidence, nature, preventability and severity of adverse drug events (ADEs) across three paediatric intensive care units (PICUs) in England. Methods:...
7.
Alghamdi A, Keers R, Sutherland A, Carson-Stevens A, Ashcroft D
Paediatr Drugs
. 2021 Apr;
23(3):287-297.
PMID: 33830469
Background: Critically ill neonates and paediatric patients may be at a greater risk of medication-related safety incidents than those in other clinical areas. Objective: This study aimed to examine the...
8.
Sutherland A, Phipps D
Jt Comm J Qual Patient Saf
. 2020 Sep;
46(12):664-666.
PMID: 32952063
No abstract available.
9.
Sutherland A, Canobbio M, Clarke J, Randall M, Skelland T, Weston E
Eur J Hosp Pharm
. 2020 Feb;
27(1):3-8.
PMID: 32064081
Objectives: Medication error is the most common type of medical error, and intravenous medicines are at a higher risk as they are complex to prepare and administer. The WHO advocates...
10.
Sutherland A, Phipps D, Tomlin S, Ashcroft D
BMC Pediatr
. 2019 Dec;
19(1):486.
PMID: 31829142
Background: Problems arising from medicines usage are recognised as a key patient safety issue. Children are a particular concern, given that they are more likely than adults to experience medication-related...